We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEA icon
101
Lear
LEA
$6.54B
$42.6M 0.33%
390,450
-33,000
-8% -$3.29M
PLD icon
102
Prologis
PLD
$135B
$41.7M 0.32%
446,535
-62,116
-12% -$5.54M
MAA icon
103
Mid-America Apartment Communities
MAA
$15.4B
$41.1M 0.32%
358,000
-26,450
-7% -$2.98M
PTC icon
104
PTC
PTC
$15.8B
$40.8M 0.31%
523,916
RCL icon
105
Royal Caribbean
RCL
$85.1B
$40M 0.31%
794,500
+329,400
+71% +$14.9M
DHI icon
106
D.R. Horton
DHI
$40B
$39.9M 0.31%
719,250
+77,000
+12% +$3.73M
APTV icon
107
Aptiv
APTV
$12B
$39.3M 0.3%
504,066
-17,656
-3% -$1.22M
HD icon
108
Home Depot
HD
$331B
$39.2M 0.3%
156,503
-11,106
-7% -$2.54M
CTXS
109
DELISTED
Citrix Systems Inc
CTXS
$39.1M 0.3%
264,509
+95,773
+57% +$13.8M
HZO icon
110
MarineMax
HZO
$759M
$37.3M 0.29%
1,665,026
-50,000
-3% -$822K
DKNG icon
111
DraftKings
DKNG
$11.6B
$37.1M 0.29%
1,114,765
+890,136
+396% +$24.6M
PJT icon
112
PJT Partners
PJT
$4.35B
$37.1M 0.29%
721,764
-55,870
-7% -$2.75M
CASY icon
113
Casey's General Stores
CASY
$32.2B
$37M 0.29%
247,270
-16,445
-6% -$2.48M
THO icon
114
Thor Industries
THO
$3.9B
$36.4M 0.28%
342,111
+32,400
+10% +$2.54M
COHR icon
115
Coherent
COHR
$51.4B
$36.2M 0.28%
766,573
-3,400
-0.4% -$135K
SWKS icon
116
Skyworks Solutions
SWKS
$9.37B
$35.8M 0.28%
280,150
-59,725
-18% -$6.62M
OMCL icon
117
Omnicell
OMCL
$1.61B
$35.6M 0.27%
503,694
-58,032
-10% -$3.97M
MRNA icon
118
Moderna
MRNA
$21.8B
$35.3M 0.27%
+550,235
New +$30.1M
SUM
119
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$35.1M 0.27%
2,217,086
ARNA
120
DELISTED
Arena Pharmaceuticals Inc
ARNA
$34.9M 0.27%
554,491
-111,092
-17% -$6.11M
HALO icon
121
Halozyme
HALO
$9.79B
$34.7M 0.27%
1,293,118
+240,144
+23% +$5.42M
BHVN
122
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$34M 0.26%
464,717
-57,100
-11% -$3.04M
CCMP
123
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$33.6M 0.26%
240,836
-11,716
-5% -$1.52M
AMZN icon
124
Amazon
AMZN
$2.92T
$33.1M 0.26%
240,000
INSM icon
125
Insmed
INSM
$21.4B
$32.7M 0.25%
1,187,901
+61,200
+5% +$1.45M

Similar funds

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.